|Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis|
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS Med 12 (4), e1001810, 2015
|HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression …|
RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ...
The Lancet infectious diseases 18 (3), 346-355, 2018
|Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study|
J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ...
The Lancet infectious diseases 16 (5), 565-575, 2016
|Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004|
V Pillay, J Ledwaba, G Hunt, M Rakgotho, B Singh, L Makubalo, ...
Antiviral therapy 13, 101, 2008
|Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor–based therapy|
A Coovadia, G Hunt, EJ Abrams, G Sherman, T Meyers, G Barry, E Malan, ...
Clinical infectious diseases 48 (4), 462-472, 2009
|Evolution and diversity of HIV-1 in Africa–a review|
MA Papathanasopoulos, GM Hunt, CT Tiemessen
Virus genes 26 (2), 151-163, 2003
|Reuse of nevirapine in exposed HIV-infected children after protease inhibitor–based viral suppression: a randomized controlled trial|
A Coovadia, EJ Abrams, R Stehlau, T Meyers, L Martens, G Sherman, ...
Jama 304 (10), 1082-1090, 2010
|Drug resistance among newly-diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis|
L Kuhn, G Hunt, KG Technau, A Coovadia, J Ledwaba, S Pickerill, ...
AIDS (London, England) 28 (11), 1673, 2014
|Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a …|
L Kuhn, A Coovadia, R Strehlau, L Martens, CC Hu, T Meyers, G Sherman, ...
The Lancet infectious diseases 12 (7), 521-530, 2012
|Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis|
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
|HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine|
GM Hunt, A Coovadia, EJ Abrams, G Sherman, T Meyers, L Morris, ...
AIDS (London, England) 25 (12), 1461, 2011
|Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal provinces, South Africa, 2005–2009|
GM Hunt, J Ledwaba, AE Basson, J Moyes, C Cohen, B Singh, ...
Clinical infectious diseases 54 (suppl_4), S334-S338, 2012
|Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys|
E Andersson, W Shao, I Bontell, F Cham, A Wondwossen, L Morris, ...
Infection, Genetics and Evolution 18, 125-131, 2013
|HIV-1 subtype A, D, G, AG and unclassified sequences identified in South Africa|
H Bredell, G Hunt, A Casteling, T Cilliers, C Rademeyer, M Coetzer, ...
AIDS research and human retroviruses 18 (9), 681-683, 2002
|Efavirenz-based antiretroviral therapy among nevirapine-exposed HIV-infected children in South Africa: a randomized clinical trial|
A Coovadia, EJ Abrams, R Strehlau, S Shiau, F Pinillos, L Martens, ...
Jama 314 (17), 1808-1817, 2015
|Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa|
BS Taylor, G Hunt, EJ Abrams, A Coovadia, T Meyers, G Sherman, ...
AIDS research and human retroviruses 27 (9), 945-956, 2011
|Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan …|
J Gregson, P Kaleebu, VC Marconi, C van Vuuren, N Ndembi, RL Hamers, ...
The Lancet infectious diseases 17 (3), 296-304, 2017
|Conserved domains of subtype C nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions|
T Mashishi, S Loubser, W Hide, G Hunt, L Morris, G Ramjee, ...
AIDS research and human retroviruses 17 (17), 1681-1687, 2001
|Occurrence of additional NF-kappaB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates|
G Hunt, CT Tiemessen
AIDS research and human retroviruses 16 (3), 305-306, 2000
|The 2012 southern African ARV drug resistance testing guidelines: Guidelines|
F Conradie, D Wilson, A Basson, T De Oliveira, G Hunt, D Joel, ...
Southern African Journal of HIV Medicine 13 (4), 162-167, 2012